Consensus BioSenic SA

Equities

Market Closed - Euronext Bruxelles Other stock markets 11:35:25 2024-04-26 EDT			5-day change	1st Jan Change
0.0156 ^EUR	-4.29%		-20.41%	-74.51%

04-11	Biosenic: launch of a debt restructuring plan	CF
03-12	Biosenic S.A. Releases Details of Optimized Administration Approach Ahead of Planned Phase 3 Trial of OATO for Chronic Graft-Versus-Host Disease	CI

8c10.o69Bk26Q6qBG6KVPjZRT08ZTyJqiievrW4O137KQmRo.x5YIzCXyvukSjeMAuLlnuqEApOr3_KaxPObWtu2i3HzV1zKqGeSB5nCw6A~bdb1b21824e6df0610a4ce79646fc190

ANALYST RECOMMENDATIONS : AT&T, BancorpSouth Bank, CMO Group, Magnite, Textron...	21-08-31
Bone Therapeutics Allogeneic Cell Therapy Product, ALLOB, Shows 90% Fusion Rate at 24 Months in Phase IIa Study in Lumbar Spinal Fusion	20-10-14	CI